Mile High Labs International Inc.
A leading supplier of compliant CBD ingredients
Mile High Labs is setting the standards for cannabidiol (CBD) ingredient manufacturing. The Company’s proprietary process yields some of the most scientifically advanced CBD available while supplying a considerable portion of the world’s overall market. Mile High’s industrial-scale laboratories and private labeling services are trusted by global partners who understand that compliance, consistency and quality are critical to success.
Scalable Systems to Match Global Demand
Mile High Labs pushes the limits of production, capacity and efficiency with proprietary technology and processes. The Company’s latest innovation is the Mile High Monster, an on-farm modular extraction facility capable of processing up to 50 acres of hemp per day. This industrial-scale production allows the largest brands to meet growing demand and deliver safe CBD products to consumers around the world.
Leading the Way in CBD Compliance
Mile High Labs is the platform of choice for the market’s most recognizable brands. CBD products that are manufactured using Mile High ingredients are marked with this seal to signify their compliance, consistency and quality. The CBD ingredients in these products are traced from farm to bottle and undergo extensive laboratory testing before reaching customers. With new products entering the market on a daily basis, consumers rely on this seal to guarantee the safety and potency of their CBD.
Founder & CEO
Stephen Mueller is the founder, Chief Executive Officer and technical visionary of Mile High Labs. After briefly working in electrical engineering, Steve saw the unique opportunity to capitalize on the CBD space. He’s been instrumental in the advancement of cannabinoid extraction, and his work has played a significant role in the creation of new technology, applications and processing methods.
Jon Hilley, Chief Financial Officer of Mile High Labs, leads the Company’s capital markets activities and financial reporting compliance. Jon began his career at Goldman Sachs before joining H.I.G. Capital as a buy-side research analyst where he learned the importance of per share value creation. This metric continues to serve as his guidelight and underpins every decision Mile High Labs makes.
Philip Von Mecklenbug
Dr. Philip v. Mecklenburg joined Mile High Labs to create the world standard for CBD supply chains. As COO, he leads the Supply Chain Department to deliver first-class products to consumers. Philip has held a variety of executive roles in the logistics industry, both in Germany and the United States. Most recently, he was responsible for DB Schenker’s New York market and created the world’s largest Freight Marketplace.
VP of Regulatory & Compliance
Wendi Young, Vice President of Regulatory and Compliance, is advancing the Company’s cGMP compliance and certification efforts. Wendi spent 17 years in the pharmaceutical industry at Tolmar Inc. where she was involved in the development of over 25 products. She’s led the implementation of FDA mandated changes, interpretation of new regulations and participated in over 20 audits from various regulatory agencies.